Saladax Biomedical has entered into a multi-year development and commercialisation deal with Bristol-Myers Squibb to produce clinical diagnostic tests for personalised medicine. The diagnostics will be used in conjunction with the development of therapeutic compounds in the Bristol ...
Please Login to read the full article.
